University of Portland

Pilot Scholars
Nursing Graduate Publications and Presentations

School of Nursing

2015

Improving Target LDL-C Levels in Diabetic
Patients Using the Electronic Health Record:
Primary Care Practice Improvement Project
Wendy Gallagher
Alicia Hinton

Follow this and additional works at: http://pilotscholars.up.edu/nrs_gradpubs
Part of the Nursing Commons
Citation: Pilot Scholars Version (Modified MLA Style)
Gallagher, Wendy and Hinton, Alicia, "Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record:
Primary Care Practice Improvement Project" (2015). Nursing Graduate Publications and Presentations. 2.
http://pilotscholars.up.edu/nrs_gradpubs/2

This Doctoral Project is brought to you for free and open access by the School of Nursing at Pilot Scholars. It has been accepted for inclusion in Nursing
Graduate Publications and Presentations by an authorized administrator of Pilot Scholars. For more information, please contact library@up.edu.

Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record:
Primary Care Practice Improvement Project
Wendy Gallagher, RN, DNP-FNP student1 & Alicia Hinton, RN, DNP-FNP student1
1

University of Portland- Portland, Oregon

Correspondence
Alicia Hinton, RN, DNP-FNP student
School of Nursing
University of Portland-Portland, 5000 N. Willamette BLVD, Portland, OR 97203
Tel: 503-313-3278 or 503-943-7211
Fax: 503-943-7729
Email: Minton15@up.edu or alicia.e.hinton@gmail.com
Keywords
Type 2 diabetes, diabetes, LDL-C, quality improvement, primary care, practice change, clinical
support tool, clinical inertia
Disclosure
No conflict of interest has been declared by the authors.
This scholarly work received no specific grant from any funding agency in the public,
commercial, or not-for-profit sectors.
The views expressed are those of the authors and not an official position of the institution.
Word Count
3233
Number of Figures/tables
One figure; one table.
Authorship
Wendy Gallagher did the literature review and developed the Diabetic LDL Protocol; Alicia
Hinton served as the primary contact with the clinic, collected and analyzed the data; both
authors collectively developed the quality improvement project, wrote the initial manuscript, and
revised the manuscript for submission.

Cover Letter

Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record:
A Primary Care Practice Improvement Project

Authorship
Both authors contributed to writing the initial manuscript. The authors have read and approved
the final manuscript. The work included is not under review by any other journal or agency. The
authors report no conflict of interest.
The manuscript is submitted in accordance with the current Guidelines for Authors (2015) for the
sole consideration of the JAANP and the material has not been published in any form previously.

Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record:
A Primary Care Practice Improvement Project
Abstract
Background and Purpose: This evidence-based project conducted a practice change in a
primary care setting to improve provider adherence in monitoring, treating and documenting
LDL-C management for adults with type 2 diabetes.
Methods: The project was conducted over 8 weeks. A clinical support tool, the Diabetic LDL
Protocol, was developed for the clinic to implement into practice. The providers were instructed
to use the tool during each encounter with an adult diabetic patient. Pre- and postimplementation data were abstracted from the electronic health records of 41 patients with type 2
diabetes during the implementation period.
Conclusions: The providers’ adherence rate for use of the Diabetic LDL Protocol peaked at 6
weeks post-implementation and declined steadily by 8 weeks. The tool was only used during
29% of the applicable patient visits. Communication issues during implementation of the
protocol and electronic health record system restrictions were contributing factors to poor
adherence.
Implications for Practice: The use of a clinical support tool may promote adherence to
guidelines for diabetic patients in primary care. Integrating the tool into the workflow of a
primary care practice and encouraging use of the tool are the major challenges of successful
implementation. Further research is necessary to investigate strategies that can overcome clinical
inertia and increase provider willingness to comply with new electronic protocols.
Introduction to the Problem
Diabetic patients have an increased risk for cardiovascular disease, with a mortality rate
from cardiac disease two to four times higher than individuals without diabetes (Nesto, 2008;
Sperl-Hillen et al., 2010). The management of low-density lipoprotein cholesterol (LDL-C) in
diabetic patients is a critical component in decreasing cardiovascular disease and mortality for
this high-risk population (Nesto, 2008; Sperl-Hillen et al., 2010). In general, primary care
providers are not meeting national standards for target LDL-C levels for their diabetic patients
(Casagrande, Fradkin Saydah, Rust, & Cowie, 2013; Davidson, 2009; Nesto, 2008; Sperl-Hillen
et al., 2010 ).

Strong evidence indicates that a reduction in LDL-C level results in a proportionate
reduction in cardiovascular disease and mortality (Cholesterol Treatment Trialists &
Collaborators, 2005, 2008; Shepherd et al., 2006). Studies have estimated that each 1.8mg/dL
decrease in LDL-C level reduces the risk of a cardiovascular event by 1% (Katcher, Hill,
Lanford, Yoo, & Kris-Etherton, 2009). Primary care providers have a variety of treatment
options to assist with LDL-C reduction, including prescribing medications, offering dietary
recommendations, and encouraging healthy lifestyle changes (Katcher et al., 2009; National
Institute of Health, 2002). Unfortunately, in a busy practice setting, the opportunity to address
LDL-C levels is often missed.
Prior Research on Diabetic Clinical Support Tools
LDL-C guidelines have existed for years, yet clinicians still have difficulty meeting these
goals for their patients (Sperl-Hillen et al., 2010). Common healthcare specific reasons cited as
barriers to implementation of these guidelines are clinician inertia and outdated paper patient
health records; clinical inertia refers to the failure of a provider to intensify a therapy when a
patient is not meeting clinical goals (Sperl-Hillen et al., 2010). Transitioning from a paper chart
system to an electronic health record (EHR) has been associated with improved glycemic and
cholesterol control for diabetic patients (Cebul, Love, Jain, & Hebert, 2011; Reed et al, 2012).
However, simply implementing the EHR may not be enough to make needed changes. The tools
and decision support that are imbedded in the EHR likely make the biggest impact in clinician
behavior and patient outcomes (Bell et al., 2010; Cebul et al., 2011; O’Connor et al., 2011;
Roshanov et al., 2011; Samal, Linder, Lipsitz, & Hicks, 2011; Sperl-Hillen et al., 2010; Weber,
Bloom, Pierdon, & Wood, 2007).

With advances in technology, one common solution is the use of the diabetic clinical
support tools integrated into the EHR (Cebul et al., 2011; Reed et al., 2012; Sperl-Hillen, et al.,
2010 ). The use of these support tools has demonstrated successful improvements in the use of
guidelines in primary care settings (Bell et al., 2010). Furthermore, the use of diabetic clinical
support tools has demonstrated increased test rates for intermediate outcomes for diabetic
patients including Hemoglobin A1c, LDL-C levels, and blood pressure (O’Connor et al., 2011;
Reed et al., 2012; Roshanov et al., 2011; Samal et al., 2011; Sperl-Hillen et al., 2010; Weber et
al., 2007.
The problem lies in the actual improvement of these values. Past studies indicated that
most clinical support tools merely improve monitoring of these outcomes and do not lead to
improved patient outcomes (Sperl-Hillen et al., 2010). Therefore, if the goal is to meet national
guidelines for a given outcome, the practice change must not only encourage a provider to obtain
lab values or perform testing but also to implement an appropriate intervention. According to
Sperl-Hillen et al. (2010), the most successful diabetic support tools overcome clinical inertia
and encourage the provider to prescribe more aggressive pharmacological and lifestyle
interventions.
In a study by Sperl-Hillen et al. (2010), the Diabetes Wizard EHR clinical decision
support tool was implemented as a randomized trial that included 41 primary care providers and
2556 diabetic patients at 11 primary care clinics. Six clinics were randomly chosen to implement
the tool, while the other clinics served as controls. The intent of the intervention was to change
provider behavior through the use of clinical support tools to ultimately improve HbA1c, blood
pressure, and LDL-C levels in type 2 diabetics. Results showed that the intervention group used
the Diabetes Wizard 62.6% of the time for adult diabetic patients, indicating that the tool was

successful in changing provider behavior. Data analysis indicated that the Diabetes Wizard
resulted in significantly improved Hb A1C and systolic blood pressure, but no significant change
in LDL-C levels occurred compared to the control group. The physicians reported high
satisfaction with the use of the tool.
Methods
This study was conducted using a pre- and post-implementation design. A baseline
review of 87 medical records was conducted to obtain a collective overall baseline adherence
rate for the providers. Post-implementation data were collected to monitor adherence rates over
the 8-week implementation period for each provider individually and collectively as group. Postimplementation data included adherence information from a total of 41 patient encounters. The
providers received a survey at four-weeks post implementation to assess their satisfaction with
the Diabetic LDL Protocol and office workflow.
Study Setting and Sampling
The study was conducted in a family-owned primary care clinic that serves
approximately 6400 patients in the Tualatin Valley of Oregon. The clinic offers comprehensive
care to individuals and families at two locations; and services include routine care, physicals,
vaccinations, respiratory care, back and neck pain, personal injury and worker’s compensation,
diabetes care and education, healthy heart care, women’s health, and in-house x-ray and blood
work. Providers include two doctors of osteopathic medicine (DOs), two family nurse
practitioners (FNPs), one physician’s assistant (PA), and multiple medical assistants (MAs).
Medical records of each patient 18 years or older with a hemoglobin A1C greater than 6% and an
LDL-C level greater than 100 mg/dL who had had an office visit with a provider at the clinic
within the 8-week implementation time frame were included in the data-collection process.

Data Collection
Provider-specific data were collected to determine adherence rates for each individual
primary care provider and then as a group. The following data were collected during the
implementation period: frequency of use of the Diabetic LDL Protocol, percent of patients with
current LDL-C levels (within the last year), percent of patients with a prescription for a lipidlowering medication, and percent of patients with appropriate ICD-9 or ICD-10 codes for
hyperlipidemia accurately documented in the EHR problem list.
Implementation Materials
An evidence-based electronic clinical decision support tool, the Diabetic LDL Protocol
(see Figure 1) was designed and implemented into the EHR at the center. Providers were given
copies of the office workflow diagram, which detailed when and how to use the Diabetic LDL
Protocol in practice. The MAs were asked to scrub the chart of each patient being seen in the
clinic at the start of the day, then to mark on the clinic’s visit summary sheet if the patient was a
diabetic, 18 years or older with a hemoglobin A1C greater than 6% and LDL-C level greater than
100 mg/dL. The provider was to then complete the Diabetic LDL Protocol during the clinical
encounter. Patient education handouts on lifestyle and dietary modifications were given to the
clinic for replication and distribution to patients. These documents served as a reminder for the
providers to follow current evidence-based practice in the management and monitoring of LDLC values in diabetic patients.

Procedures
This study was approved by the University of Portland (Oregon)’s institutional review
board. Participation in the project was voluntary and all subjects signed an informed consent.
Project authors signed confidentiality agreements at the clinic to ensure patient confidentially
and protection of personal health information. All information collected was de-identified and
anonymous.
Prior to their implementation of the Diabetic LDL Protocol, the clinic providers attended
a 60-minute educational session. Information regarding the importance of LDL-C management
in diabetics and the intent and use of the Diabetic LDL Protocol were discussed. The staff
members were instructed on the workflow changes that would be necessary to implement the
new protocol, and providers received education on lifestyle and dietary approaches to lowering
lipid levels. Providers were also encouraged to ask questions and propose changes to the office
workflow and Diabetic LDL Protocol. Emails, meetings, and a formal presentation were used to
ensure that instructions were provided and expectations were established for implementation. A
target LDL-C goal was agreed upon and set at less than 100mg/dL for patients with a
hemoglobin A1c greater than 6%.
Data were collected from the EHR of patients who met inclusion criteria prior to
implementation. The Diabetic LDL Protocol was then implemented over an eight-week period of
time. After four weeks, six weeks, and eight weeks post-implementation, the EHR of eligible
patients were reviewed.
Data Analysis
Frequencies were used to determine differences between pre- and post-implementation
rates of the percent of patients with current LDL-C levels (within the last year), percent of

patients with a prescription for a lipid-lowering medication, and percent of patients with
appropriate ICD-9 or ICD-10 codes for hyperlipidemia accurately documented in the EHR
problem list. Provider adherence to use of the Diabetic LDL Protocol was assessed by
determining frequency of use over the implementation period.
Results
Sample Characteristics
Eighty-seven medical records were reviewed prior to implementation. Among these
patients, 47 (54%) had a LDL-C level documented within the last 12 months, 42 (48%) were
prescribed a lipid-lowering medication, and 69 (79%) had an appropriate ICD- 9 code
documented related to their elevated LDL-C level. Care was provided by five providers: two
DOs, two NPs, one PA and their five MAs.
Use of Diabetic LDL Protocol
At four weeks post-implementation, there had been 12 patient encounters that met the
requirements for use of the Diabetic LDL Protocol; however, none of the providers had used the
protocol during these encounters. Between weeks four and six, 20 patient encounters met the
requirements for use of the Diabetic LDL Protocol and it was used during 11 (55%) of these
patient encounters. Among these patients, 14 (70%) had a LDL-C level documented within the
last 12 months, 12 (60%) were prescribed a lipid-lowering medication, and 16 (80%) had an
appropriate ICD- 9 code documented related to their elevated LDL-C level. At eight weeks postimplementation, there had been 9 additional patient encounters and the Diabetic LDL Protocol
was used during only one (11%) of these patient encounters. Among these patients, 5 (56%) had
a LDL-C level documented within the last 12 months, 8 (89%) were prescribed a lipid-lowering

medication, and 9 (100%) had an appropriate ICD- 9 code documented related to their elevated
LDL-C level.
At eight weeks post-implementation, a total of 41 patient encounters had met the
requirements for use of the Diabetic LDL Protocol, and the protocol was used during 12 (29%)
of them. Among these 41 patients, 28 (68%) had a LDL-C level documented within the last 12
months, 27 (66%) were prescribed a lipid-lowering medication, and 35 (85%) had an appropriate
ICD- 9 code documented related to their elevated LDL-C level (see Table 1).
Table 1
Pre- and Post-Implementation Results of Outcome Measures
Category
Frequency Percent
Pre-implementation (n= 87)
LDL-Ca <12 months
47
54
Medication
42
48
ICD-9b
69
79
Post-implementation (4 weeks; n= 12)
Protocol used
0
0
LDL-C <12 months
9
75
Medication
7
58
ICD-9
10
83
Post-implementation (6 weeks; n=20)
Protocol used
11
55
LDL-C <12 months
14
70
Medication
12
60
ICD-9
16
80
Post-implementation (8 weeks; n=9)
Protocol used
1
11
LDL-C <12 months
5
56
Medication
8
89
ICD-9
9
100
aLDL-C
bICD-9

= low-density lipoprotein cholesterol
= international classification of diseases, 9th rev.

Processes of Implementation
Providers were given a survey at four weeks post-implementation to assess their
satisfaction with the pre-implementation education regarding the purpose of the Diabetic LDL
Protocol and clinic workflow as well as ease of use and value in caring for diabetic patients.
Providers were asked to rate their satisfaction on a Likert scale ranging from 1 (very dissatisfied)
to 5 (very satisfied). Open-ended questions were asked so providers could offer feedback and
suggest changes moving forward. Surveys were given to the five primary care providers and
their five MAs as well as the RN care manager; 64% of the surveys were returned, all
anonymously.
Of the respondents, 57% indicated they were satisfied with the 60-minute education
session given prior to implementation; the remaining 43% of respondents did not attend the
education session. Providers expressed that they found education regarding the importance of
managing LDL-C values in diabetics beneficial. One provider wanted coaching on interacting
with patients regarding LDL-C values. Providers were either satisfied (43%) or neutral (43%)
regarding office workflow. Feedback included increasing communication in the clinic and more
involvement from the MAs in checking LDL-C values. Of the providers, 29% found the Diabetic
LDL Protocol valuable in caring for diabetic patients, the other 71% were indifferent. Providers
thought the Diabetic LDL Protocol reminded them to use statins in diabetics, order lipid panels if
the last LDL-C value was more than 12 months earlier, and that the overall goal of the protocol
was to improve the health of patients.

Discussion
There were no significant increases in LDL-C monitoring, medication management, or
ICD-9 documentation in the post-implementation phase. The data reflect overall trends in LDLC documentation, prescribing of medications, and ICD-9 code documentation for the patients
during the implementation period. Since the providers may have already met these requirements
prior to the encounter during the study, the values do not necessarily indicate that the use of the
protocol led to changes in provider behavior. However, use of the protocol may be associated
with improved LDL-C management.
Use of the Diabetic LDL Protocol peaked at 6 weeks and steadily declined by 8 weeks.
These findings are consistent with previous studies, which have shown that merely using
electronic alerts in the EHR does not improve patient outcomes; changes are best made when
clinical support tools encourage a provider to implement the appropriate intervention (SperlHillen et al., 2010).
Results of this study demonstrate that electronic alerts and inferior clinical support tools
do not overcome clinical inertia in the management of LDL-C values in diabetics. Providers at
the clinic were not providing care consistent with national guidelines targeting LDL-C values in
diabetics both prior to and after the implementation as evidenced by failure to use the Diabetic
LDL Protocol and to more aggressively treat elevated LDL-C values.
An important factor to consider when determining the potential impact of the electronic
tool on patient outcomes is the capability of the clinic’s EHR system. Due to restrictions within
the EHR system at this clinic, the staff were unable to fully create an electronic version of the
Diabetic LDL Protocol as initially designed by the project authors. The clinic was only able to
create a tool that asked providers if a patient’s LDL-C was greater than 100 mg/dL and, if so, to

ask if an educational handout on diet was given and if the patient was on statins. They were
unable to create an algorithm that could incorporate ordering of lab values, making medication
adjustments, documenting the appropriate ICD-9 code, and recommending appropriate followup. Since the design of the protocol was adjusted to fit the clinic’s EHR capabilities and was not
fully used as intended, improved compliance with the Diabetic LDL Protocol may not
necessarily result in improved patient outcomes overtime.
Previous studies have demonstrated that the success to implementing practice change lies
in clear communication about the purpose and process of the implementation as well as early
buy-in from medical staff (O’Connor et al., 2011; Sperl-Hillen et al., 2010). The results of this
study reinforce the importance of frequently communicating the purpose and process of the
intervention both pre- and post-implementation. Thus, the lack of provider adherence and use of
the Diabetic LDL Protocol, and a more aggressive management of LDL-C values may be
contributed to insufficient communication regarding the purpose and process of implementation
as evidenced by one provider stating he or she was unaware of the protocol four weeks postimplementation. Furthermore, post-implementation communication was mainly focused on the
primary care providers and not the MAs, which is likely to have impacted adherence rates due to
increased burden of responsibility on the primary care providers.
Limitations
The limitations of this study must be considered when assessing its implications to the
care of patients with diabetes. First, the study was limited to a small family-owned primary care
clinic in the Tualatin Valley of Oregon, which may differ from other care settings and
geographical locations. As previously mentioned, the protocol was not implemented as initially
designed. Due to constraints within the EHR, the clinic’s informatics department created an

alternative version of the evidence-based protocol. These changes likely impacted the quality of
the electronic tool.
The small sample size is an additional limitation. Only five primary care providers
practiced within the clinic during the study, and they saw a total of 41 patients who met inclusion
criteria for EHR review. The small sample size and short duration of the study pose the questions
of whether the Diabetic LDL Protocol will be used in the long term. Furthermore, the short
duration of the study was such that patient outcomes were not tracked. It is unknown if use of the
Diabetic LDL Protocol will affect changes in patient outcomes at this clinic.
Implications
Implications for Practice
The findings of this study are relevant to primary care clinical practice. Findings indicate
that the use of health management tools in the EHR helps providers adhere to evidence-based
recommendations regarding LDL-C management in diabetics. Unfortunately, the EHR at the
clinic was unable to fully support the Diabetic LDL Protocol in its entirety, likely decreasing its
ability to effect changes in patients’ LDL-C values. In order for clinics to fully comply with
reporting and demonstrating meaningful use of the EHR in order to receive reimbursement under
the Medicare and Medicaid Electronic Health Record Incentive Program (Centers for Medicare
and Medicaid Services, 2014), EHRs need to be able to support health management tools and
algorithms designed to increase provider compliance with evidence-based practice. Furthermore,
use of health management tools embedded in the EHR should be accompanied by periodic chart
audits to determine adherence with practice recommendations and to monitor changes in patient
outcomes. Data collection, even with an EHR, can be a tedious process. By embedding health
management tools into the EHR in a way that automatically collects, analyzes, and provides a

breakdown of data can benefit a clinic’s ability to track provider compliance and patient
outcomes (Umar-Kamara & Tufts, 2013).
Implications for Research
Findings from this study have implications for future research. Longer studies should be
conducted across different primary care settings and with control groups to determine provider
acceptance and compliance with electronic Diabetic LDL-C support tools such as the Diabetic
LDL Protocol, and to track patient outcomes. Results from future studies can help determine how
to best use EHRs to improve the quality of care provided to diabetics with elevated LDL-C
levels.
Conclusion
This clinic will not likely experience an improvement in patient outcomes without more
aggressive medical and lifestyle management for its diabetic population. Considering the EHR
limitations and the communication issues regarding the new protocol, practice change seems
unlikely under the current conditions. Further attempts to change practice at this clinic will
require updates to the EHR system that will enhance ease of use and will incorporate all the
necessary components of LDL-C management. Improved communication methods and
additional support and training will be necessary to increase provider buy-in to inspire practice
change and promote sustainability.

Diabetic LDL Protocol

**** Patient Information ****
Value
LDL-Ca
xxmg/dL/ or none on file

Date
00/00/00

Goal
<100mg/dL

Current LDL-C lowering medication:
XYZ or none on file

Does patient have a current LDL-C value (within the past 12-months?)
- No: order fasting lipid panel
- Yes: is LDL-C greater than 100mg/dL?
- No: no changes to therapy
- Yes: consider lifestyle modifications and/or medication

**** Treatments to Consider ****
* Lifestyle modifications
- Diet: TLCb, portfolio, Mediterranean diet
- Exercise, smoking cessation, limit alcohol consumption, weight management
* Consider ordering/increasing lipid-lowering medication with lifestyle modifications

**** Follow-Up ****
Consider follow-up visits every 8 weeks until better LDL-C control is achieved!

How was LDL-C treatment modified?
- Lifestyle modification
- Lifestyle modification AND medication
- Medication
- No treatment given (why)

Figure 1. Diabetic LDL protocol.
a
LDL-C = low-density lipoprotein cholesterol
b
TLC = therapeutic lifestyle changes
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